Clinical trial
Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent…
NCT00338221 · University of Virginia, Other · Withdrawn
Key facts
| NCT number | NCT00338221 |
|---|---|
| Title | Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition |
| Official title | Prospective Double Blinded Randomized Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition |
| Lead sponsor | University of Virginia, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diarrhea, Malnutrition |
| Intervention type | Drug |
| Interventions | alanyl-glutamine, glycine |
| Enrollment | 108 |
| Start date | Aug 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Jun 20, 2006 |
| Last update posted | Oct 28, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: